By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Halozyme Therapeutics, Inc. 

11388 Sorrento Valley Road

San Diego  California  92121  U.S.A.
Phone: 858-794-8889 Fax: 858-259-2539

Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the dispersion and absorption of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer, Baxter, and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at

Key Statistics

Ownership: Public

Web Site: Halozyme
Employees: 152
Symbol: HALO

Company News
MabVax Therapeutics Studies Lead Investigational Drug MVT-5873 With Halozyme (HALO) PEGPH20 2/13/2017 6:48:33 AM
Halozyme (HALO) Release: Pharma Company Provides Program Updates, 2017 Financial Guidance At 35th Annual JP Morgan Healthcare Conference 1/10/2017 9:50:30 AM
Halozyme (HALO) Announces Phase 2 Study In Advanced Pancreas Cancer Meets Key Endpoints 1/5/2017 6:22:07 AM
Halozyme (HALO) Announces Broad Clinical Collaboration Agreement To Evaluate PEGPH20 And Tecentriq In Up To Eight Tumor Types 11/11/2016 2:26:18 PM
Halozyme (HALO) Reports Third Quarter 2016 Financial Results 11/8/2016 12:43:19 PM
Halozyme (HALO) To Host Third Quarter 2016 Financial Results Conference Call 10/14/2016 11:51:20 AM
Halozyme (HALO) Release: PEGPH20 Selected For Inclusion In Groundbreaking Clinical Trial Initiative Designed To Transform Outcomes For Pancreatic Cancer Patients 10/4/2016 8:15:54 AM
Halozyme (HALO) To Present At The Bank of America (BAC) Merrill Lynch 2016 Global Health Care Conference 9/9/2016 8:34:06 AM
Halozyme (HALO) To Present At Upcoming Healthcare Conferences 9/1/2016 12:02:06 PM
Halozyme (HALO) Names Mark J. Gergen As Chief Operating Officer 9/1/2016 10:19:37 AM